MX2009008734A - Gamma lactamas para el tratamiento de glaucoma o hipertension intraocular. - Google Patents
Gamma lactamas para el tratamiento de glaucoma o hipertension intraocular.Info
- Publication number
- MX2009008734A MX2009008734A MX2009008734A MX2009008734A MX2009008734A MX 2009008734 A MX2009008734 A MX 2009008734A MX 2009008734 A MX2009008734 A MX 2009008734A MX 2009008734 A MX2009008734 A MX 2009008734A MX 2009008734 A MX2009008734 A MX 2009008734A
- Authority
- MX
- Mexico
- Prior art keywords
- lactams
- glaucoma
- gamma
- treatment
- intraocular pressure
- Prior art date
Links
- 208000010412 Glaucoma Diseases 0.000 title 1
- 230000004406 elevated intraocular pressure Effects 0.000 title 1
- 150000003953 γ-lactams Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/263—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
- C07D207/267—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Ophthalmology & Optometry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US89018107P | 2007-02-15 | 2007-02-15 | |
| PCT/US2008/053386 WO2008100809A1 (en) | 2007-02-15 | 2008-02-08 | Gamma-lactams for the treatment of glaucoma or elevated intraocular pressure |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2009008734A true MX2009008734A (es) | 2009-08-25 |
Family
ID=39511007
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2009008734A MX2009008734A (es) | 2007-02-15 | 2008-02-08 | Gamma lactamas para el tratamiento de glaucoma o hipertension intraocular. |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US8362054B2 (OSRAM) |
| EP (1) | EP2118094B1 (OSRAM) |
| JP (1) | JP5566696B2 (OSRAM) |
| KR (1) | KR20090109587A (OSRAM) |
| CN (1) | CN101657445B (OSRAM) |
| AU (1) | AU2008216499B2 (OSRAM) |
| BR (1) | BRPI0807600A2 (OSRAM) |
| CA (1) | CA2678191A1 (OSRAM) |
| ES (1) | ES2404169T3 (OSRAM) |
| MX (1) | MX2009008734A (OSRAM) |
| NZ (1) | NZ598945A (OSRAM) |
| WO (1) | WO2008100809A1 (OSRAM) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ585103A (en) * | 2007-10-23 | 2012-04-27 | Allergan Inc | Substituted lactams derivatives and their uses for glaucoma and ocullar hypertension |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2004521954A (ja) * | 2001-07-16 | 2004-07-22 | エフ．ホフマン−ラ ロシュ アーゲー | Ｅｐ４受容体作用薬としてのプロスタグランジン類似体 |
| KR100437972B1 (ko) * | 2001-10-27 | 2004-07-02 | 한국과학기술연구원 | 피롤리디논 유도체, 이의 제조 방법 및 이를 포함하는제약 조성물 |
| CN1653046A (zh) * | 2002-03-05 | 2005-08-10 | 小野药品工业株式会社 | 8－氮杂前列腺素衍生化合物以及包含该化合物作为活性成分的药物 |
| US6573294B1 (en) * | 2002-05-14 | 2003-06-03 | Allergan, Inc. | 8-azaprostaglandin analogs as agents for lowering intraocular pressure |
| US7419999B2 (en) * | 2002-06-10 | 2008-09-02 | Applied Research Systems Ars Holding N.V. | Gamma lactams as prostaglandin agonists and use thereof |
| AU2003275838A1 (en) * | 2002-10-25 | 2004-05-13 | Beunard, Jean-Luc | Pyrrolidin-2-on derivatives as ep4 receptor agonists |
| US7091231B2 (en) | 2004-12-10 | 2006-08-15 | Allergan, Inc. | 12-Aryl prostaglandin analogs |
| US20080249028A1 (en) | 2005-03-09 | 2008-10-09 | Roger Williams Hospital | Thyrotropin-Releasing Hormone Analogs and Method of Use |
| CN105520941B (zh) * | 2005-03-10 | 2020-05-01 | 阿勒根公司 | 作为治疗剂的取代的γ内酰胺 |
| CA2645867A1 (en) | 2006-03-20 | 2007-09-27 | Allergan, Inc. | Substituted gamma lactams as prostaglandin ep2 agonists |
-
2008
- 2008-02-08 BR BRPI0807600-6A patent/BRPI0807600A2/pt not_active IP Right Cessation
- 2008-02-08 CA CA002678191A patent/CA2678191A1/en not_active Abandoned
- 2008-02-08 US US12/527,155 patent/US8362054B2/en not_active Expired - Fee Related
- 2008-02-08 MX MX2009008734A patent/MX2009008734A/es active IP Right Grant
- 2008-02-08 KR KR1020097018979A patent/KR20090109587A/ko not_active Ceased
- 2008-02-08 JP JP2009549670A patent/JP5566696B2/ja not_active Expired - Fee Related
- 2008-02-08 NZ NZ598945A patent/NZ598945A/xx not_active IP Right Cessation
- 2008-02-08 EP EP08729358.5A patent/EP2118094B1/en not_active Not-in-force
- 2008-02-08 ES ES08729358T patent/ES2404169T3/es active Active
- 2008-02-08 WO PCT/US2008/053386 patent/WO2008100809A1/en not_active Ceased
- 2008-02-08 CN CN2008800120472A patent/CN101657445B/zh not_active Expired - Fee Related
- 2008-02-08 AU AU2008216499A patent/AU2008216499B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| AU2008216499B2 (en) | 2014-04-17 |
| US8362054B2 (en) | 2013-01-29 |
| AU2008216499A1 (en) | 2008-08-21 |
| JP5566696B2 (ja) | 2014-08-06 |
| EP2118094B1 (en) | 2013-04-17 |
| ES2404169T3 (es) | 2013-05-24 |
| US20100168189A1 (en) | 2010-07-01 |
| WO2008100809A1 (en) | 2008-08-21 |
| BRPI0807600A2 (pt) | 2014-07-22 |
| JP2010519208A (ja) | 2010-06-03 |
| CA2678191A1 (en) | 2008-08-21 |
| KR20090109587A (ko) | 2009-10-20 |
| NZ598945A (en) | 2013-08-30 |
| CN101657445A (zh) | 2010-02-24 |
| CN101657445B (zh) | 2013-06-05 |
| EP2118094A1 (en) | 2009-11-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2009001062A (es) | Agonistas de ep2. | |
| MX2009006704A (es) | Derivados de amina triciclicos como inhibidores de proteina de tirosina cinasa. | |
| TN2010000122A1 (en) | Compounds and compositions as modulators of gpr119 activity | |
| MX2009009491A (es) | Compuestos y composiciones como moduladores de la actividad del gpr119. | |
| WO2012047587A3 (en) | Mdm2 inhibitors for treatment of ocular conditions | |
| WO2009129246A3 (en) | Compositions and methods for preparing and using same | |
| MY173616A (en) | Compositions and methods for lowering triglycerides | |
| MX343135B (es) | Compuestos de tipo fumagilol y métodos de realización y uso de los mismos. | |
| TW200736233A (en) | Cyclohexyl piperazinyl methanone derivatives | |
| MX2008013196A (es) | 5-amido-2-carboxiamida-indoles. | |
| MX2010006204A (es) | Derivados de oxindol 5,6-disubstituidos y el uso de los mismos para el tratamiento de enfermedades dependientes de la vasopresina. | |
| UA103930C2 (ru) | Соединения и композиция для лечения паразитарных болезней | |
| WO2010121164A3 (en) | 1,4-benzodiazepinone compounds and their use in treating cancer | |
| MY159244A (en) | Method of reducing intraocular pressure in humans | |
| MX2010006206A (es) | Derivados de oxindol substituidos por 5-halogeno y el uso de los mismos para el tratamiento de enfermedades dependientes de la vasopresina. | |
| TW200738651A (en) | Cyclohexyl sulfonamide derivatives | |
| WO2009074247A8 (de) | Neue 2-aryl-thiazol-4-carbonsäureamid-derivate, deren herstellung und verwendung als arzneimittel | |
| GEP20156224B (en) | Therapeutic agent for mood disorders | |
| MX2008015775A (es) | Compuestos y composiciones para tratamiento de cancer. | |
| MY150931A (en) | Substituted oxazolidinones and their use | |
| WO2008008700A3 (en) | Substituted cyclopentane derivatives as therapeutic agents | |
| WO2010012745A3 (en) | Benzimidazoles | |
| WO2009078978A3 (en) | Compositions containing polyglycidol-based polymers and uses thereof | |
| MX2011011618A (es) | Agentes terapeuticos 713. | |
| WO2007130890A3 (en) | Cyclopentane-derivatives and their use as ocular hypotensive agents |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |